Drug Database
Back to search

Netherlands· NL-ef87668513d2

Abecma 260-500 x 10^6 cellen dispersie voor infusie

A idecabtagene vicleucel product containing idecabtageen vicleucel, registered in Netherlands by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 10 of our 19 countries.

ATC L01XL07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAbecma 260-500 x 10^6 cellen dispersi…ATCL01XL07REGISTER NO.NL-ef87668513d2PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about idecabtageen vicleucelAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Idecabtagene vicleucel is registered in 10 of 19 countries.

Countries holding a registration under ATC L01XL07 (idecabtagene vicleucel), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search idecabtagene vicleucel products by name

Idecabtagene vicleucel · ATC L01XL07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
IDECABTAGEEN VICLEUCEL
Manufacturer
Bristol-Myers Squibb Pharma EEIG
Country
Netherlands (NL)
ATC code
L01XL07
ATC class
Idecabtagene vicleucel
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/21/1539

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Idecabtagene vicleucel in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All idecabtagene vicleucel products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Abecma
  • Liechtenstein · Abecma
  • Norway · Abecma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f4aabd95-8112-487a-80c1-78ae95af40e7
GET /v1/drugs/f4aabd95-8112-487a-80c1-78ae95af40e7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersie voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/abecma-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Idecabtagene Vicleucel",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp126772",
  "excipients": [
    "ADENOSINE",
    "CALCIUMCHLORIDE 2-WATER (E 509)",
    "DEXTRAAN 40",
    "DIMETHYLSULFOXIDE",
    "GLUCOSE 0-WATER",
    "GLUTATHION (L-)",
    "KALIUMCHLORIDE (E 508)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "KALIUMHYDROXIDE (E 525)",
    "KALIUMWATERSTOFCARBONAAT (E 501 (II))",
    "LACTOBIONZUUR",
    "MAGNESIUMCHLORIDE 6-WATER (E 511)",
    "MANNITOL (D-) (E 421)",
    "N-2-HYDROXYETHYLPIPERAZINE-N'-2-ETHAANSULFONZUUR",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "NATRIUMGLUCONAAT (E 576)",
    "SACCHAROSE",
    "WATER VOOR INJECTIE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "IDECABTAGEEN VICLEUCEL"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/08/18",
  "procedure_number": "EMEA/H/C/004662",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/21/1539",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about idecabtagene vicleucel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console